Upton and DeGette: “Cures and treatments today can be developed at the molecular level, giving patients treatments tailored specifically to their genetic makeup.”
WASHINGTON, DC – The Energy and Commerce Committee will continue its efforts on 21st Century Cures with a roundtable next Wednesday, July 23, 2014, at 10 a.m., in room 2123 of the Rayburn House Office Building. Members and participants will discuss how the rise of personalized medicine and advances in science and technology can shape the health care system in the 21st century. Specifically, the roundtable will explore how genomic sequencing and diagnostic testing, as well as the regulation of these continually evolving areas, affects innovative product development and delivery.
“Thanks to the incredible advances made over the past several decades, cures and treatments today can be developed at the molecular level, giving patients treatments tailored specifically to their genetic makeup,” commented Chairman Fred Upton (R-MI) and Rep. Diana DeGette (D-CO). “21st Century Cures is about spurring innovation to advance a system of personalized medicine so that patients can get the right treatment at the right time for their unique health care needs. We look forward to hearing more about the opportunities on the horizon and what role Congress can play in moving solutions forward.”
A live stream of the event and participant list will be made available here.